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Abstract
Epilepsy is a debilitating neurological disorder characterised by recurrent seizures for which 30% of patients are refractory to
current treatments. The genetic and molecular aetiologies behind epilepsy are under investigation with the goal of developing
new epilepsy medications. The transcriptional repressor REST (Repressor Element 1-Silencing Transcription factor) is a focus of
interest as it is consistently upregulated in epilepsy patients and following brain insult in animal models of epilepsy and ischemia.
This review analyses data from different epilepsy models and discusses the contribution of REST to epileptogenesis. We propose
that in healthy brains REST acts in a protective manner to homeostatically downregulate increases in excitability, to protect
against seizure through downregulation of BDNF (Brain-Derived Neurotrophic Factor) and its receptor, TrkB (Tropomyosin
receptor kinase B). However, in epilepsy patients and post-seizure, REST may increase to a larger degree, which allows
downregulation of the glutamate receptor subunit GluR2. This leads to AMPA glutamate receptors lacking GluR2 subunits,
which have increased permeability to Ca2+, causing excitotoxicity, cell death and seizure. This concept highlights therapeutic
potential of REST modulation through gene therapy in epilepsy patients.
Keywords Epilepsy . BDNF . Potassium channel . Transcription . Epigenetics
Introduction
Epilepsy is a prevalent neurological disorder impacting qual-
ity of life for 50 million people worldwide. Patients suffer
from recurrent seizures caused by excessive firing of neurons
in the brain which can often lead to hippocampal sclerosis and
further deterioration. Around 30% of patients are refractory to
treatment, current antiepileptic drugs often create unpleasant
side effects and there are no preventative or disease-modifying
epilepsy therapies. The most common type of epilepsy in
adults is temporal lobe epilepsy, but acquired epilepsy is also
a common result of a stroke in elderly people. Other causes are
traumatic brain injury, infection or hypoxia during birth. The
process of acquiring or developing epilepsy is called
epileptogenesis. During epileptogenesis, the homeostatic
mechanismswhich protect against hyperexcitability in healthy
neurons become unbalanced as the initial insult alters gene
expression patterns. This is accompanied by excitotoxicity
and neuronal degeneration, aberrant mossy fibre sprouting,
and astrocyte-mediated inflammation (Dingledine et al. 2014).
Various animal models of epilepsy have been developed in
recent decades. While no single model recreates every aspect
of all epilepsies, most replicate the majority of neuropatholog-
ical traits with reasonable accuracy, and the type of model
used per experiment is chosen specifically for each research
question. The electrical kindling model was developed in
1967, and consists of repeated short, mild tetanic stimulations
every 12 or 24 h for weeks, leading to seizures of increasing
severity. In the pentylenetetrazole (PTZ) kindling model, kin-
dling is induced by an injection of a subconvulsive dose of the
GABAA antagonist PTZ every 2 days for up to 43 days.
Kindled rodents do not typically have spontaneous seizures,
but they are very easily susceptible to triggered seizures.
However, animals kindled for prolonged times consisting of
hundreds of trials can exhibit spontaneous seizures
(Michalakis et al. 1998). In post status-epilepticus (SE) epi-
lepsy models, SE can be induced by chemoconvulsants or a
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strong electrical stimulation. Most post-SE models use
kainate, a glutamate analog. One large (18 mg/kg) or a few
smaller (5 mg/kg) kainate injection(s) at 30 min intervals in-
duces SEwithin hours, followed by a latent period and then an
epilepsy-like state where spontaneous seizures can reccur in-
definitely. Post-SE models are favoured for investigations of
epileptogenesis because this process occurs during the latent
period in patients following an initial brain insult. One com-
mon insult in the elderly population is strokes, with post-
stroke epilepsy accounting for the majority of epilepsy cases
in the elderly.
Epileptogenesis alters patterns of gene expression within
affected brain regions. One gene of interest which is differen-
tially regulated in epilepsy is the transcription factor Repressor
Element 1-Silencing Transcription factor (REST)/Neuron
Restrictive Silencer Factor (NRSF). REST is a widespread
transcriptional repressor which binds to a 21-bp Repressor
Element 1 (RE1)/Neural Restrictive Silencer Element
(NRSE) region on its target genes via its zinc finger domain
(Chong et al. 1995; Schoenherr and Anderson 1995). REST is
found at high levels in non-neuronal tissues, its down-
regulation is believed to be important in neuronal differentia-
tion but it also acts as a regulator of gene expression in mature
neurons (Schoenherr et al. 1996; Palm et al. 1998; Wood et al.
2003; Ooi and Wood 2007; Ballas et al. 2005). REST protein
and mRNA have been found in widespread brain regions in
the adult rat, including neurons in all layers of the cerebral
cortex, the dentate gyrus granule cell formation and pyramidal
cell layer in the hippocampus (Palm et al. 1998). There is no
indication from published data that REST expression is con-
fined to specific subclaasess of neurons. In silico analysis
highlighted up to 1892 potential RE1 sites in the human ge-
nome (R. Johnson et al. 2006; Bruce et al. 2004) and
orthologues across 16 other vertebrate genomes (R. Johnson
et al. 2009), most of which have REST binding validated
in vivo (D.S. Johnson et al. 2007). REST represses transcrip-
tion by recruiting repressor complexes via N and C-terminal
domains. The N-terminal domain recruits mSin3 (Grimes
et al. 2000) and histone deacetylases (HDACs) 1 and 2
(Huang et al. 1999; Naruse et al. 1999; Roopra et al. 2000).
Meanwhile the C-terminal domain recruits REST corepressor
1 complex [Co-REST, (Andrés et al. 1999)], which consists of
further recruitment of HDACs 1 and 2, and BRG1 which
stabilises REST interactions with DNA (Ooi et al. 2006; Ooi
and Wood 2007). The C-terminal region also recruits the
H3K4 demethylase LSD1, and the H3K9 methylase G9a
(Roopra et al. 2004; Shi et al. 2004).
In animal models, REST mRNA and protein levels are
consistently upregulated following induced status-epilepticus
or ischemia. This occurrence across different studies is de-
tailed in Table 1. Such increases in REST represent the obser-
vations of epileptogenesis in humans, as REST mRNA and
protein levels are overexpressed in epilepsy patients, with the
level of REST protein correlating with the frequency of sei-
zures (Navarrete-Modesto et al. 2019). Kainate-induced epi-
leptic seizures cause increased REST mRNA levels in rat hip-
pocampal and cortical neurons in vivo (Palm et al. 1998;
Spencer et al. 2006). Kainate-induced seizures in rats causes
an upregulation of RESTmRNA and protein for 4–48 h with a
downregulation of REST target genes (Brennan et al. 2016;
McClelland et al. 2011), and REST protein peaks at 24 h after
kainate injection (Carminati et al. 2019). REST mRNA and
protein was upregulated 24 h after pilocarpine injection, or
24 h after kindling (Hu et al. 2011a, 2011b). Interestingly,
REST protein expression was increased after kindling in rats
which were resistant to kindling after 20 PTZ injections,
whereas REST was unchanged from control in rats which
were successfully kindled after 1, 5, 10 or 20 injections
(Chmielewska et al. 2020), highlighting an association be-
tween REST increase and protection against seizures in this
study. Because of its upregulation following neurological in-
sult, REST has gained some attention from research groups
trying to elucidate its contribution to the epileptogenic
process.
Effects of REST in post status-epilepticus
seizure models
Status epilepticus (SE) in animals can be induced by a high
dose injection, or a few lower dose injections of a
chemoconvulsant, or a high frequency train of electrical stim-
ulation. After the induced SE is a latent period leading to the
development of spontaneous seizures. The most commonly
used inducer of SE is kainate; a glutamate analog, and agonist
of kainate receptors. Seizures and hippocampal damage from
kainate injection was first described by Ben-Ari and col-
leagues (Ben-Ari et al. 1978). Kainate can induce status epi-
lepticus following injection into the amygdala, hippocampus
or ventricles. If injected into the hippocampus or amygdala,
status epilepticus begins at the injection site and spreads to the
ipsilateral and contralateral hippocampus, amygdala and cor-
tex, inducing seizures within hours. This can cause neuronal
loss and astrogliosis at the injection site which propogates to
the hippocampus and amygdala, beginning with the hippo-
campal CA3 (Ben-Ari et al. 1980). Kainate has been observed
causing excitotoxicity, hippocampal sclerosis and mossy fiber
sprouting (de Montigny and Tardif 1981; Leite et al. 1996), as
well as increasing blood brain barrier permeability. In rats
with severe but not mild kainate-induced limbic seizures,
blood brain barrier permeability was increased throughout
the brain 2–24 h after kainate injection, before mostly
returning to normal (Zucker et al. 1983). After a latency period
rats then develop spontaneous recurrent seizures (Williams
et al. 2009), which continue for life. A bulk of research on
the functions of REST in epileptogenesis has been done using
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post-SE models such as kainate or the cholinomimetic pilo-
carpine. Here we will introduce what has been discovered
about the mechanism of REST upregulation following SE
and some post-SE REST targets.
How is REST upregulated following neuronal insult?
Sirt1 is a NAD+ sensitive histone deacetylase which responds
to changes in cellular energy demand by changing chromatin
state and gene transcription. Activity of Sirt1 is increased in
epilepsy patients and animal epilepsy models (Chen et al.
2013), suggesting that it could be involved in epileptogenesis.
In 2016 the Baram group uncovered more details about how
seizure causes REST to increase and found the process to be
Sirt1 dependent. Kainate-induced SE in rats led to reduced
microRNA-124 (miR-124) via histone deacetylation by
Sirt1. The reduction in miR-124 allowed an upregulation of
REST via C/EBPα increase, which had a functional effect on
REST target genes, whose expression was decreased. Infusion
of miR-124 agomirs also prevented REST upregulation and
rescued REST target genes, though it increased inflammation
and did not reduce seizures (Brennan et al. 2016). In contrast,
after observing a similar downregulation of miR-124 in rats
post-seizure, the Luo group administered miR-124, which al-
leviated PTZ and pilocarpine-induced seizures. miR-124 in-
jection targeted and repressed cAMP-response element-bind-
ing protein 1 (CREB1), a known epileptogenesis regulator
(Wang et al. 2016), highlighting CREB1 as an additional
miR-124-involving pathway in seizure control that is REST-
independent. miR-124 has been suggested to have a dual ef-
fect in chemoconvulsant models of attenuating seizures by
inhibiting expression of REST, CREB, C/EBPα and
Table 1 List of studies using animal models of epilepsy to assess effects
of insult on REST levels, and effects of REST inhibition on epilepsy
pathology. Kainate (KA), PTZ, kindling and ischemia all lead to an
increase in REST mRNA and protein. This REST increase can be
blocked by various methods including shRNA and siRNA
knockdowns, decoy oligonucleotides and cre-loxp knockout. REST is
described as anti-seizure in kindling studies, pro-seizure in post-SE epi-
lepsy models, and pro-neurodegeneration after ischemia
Model Effect on REST REST inhibition Response Role of REST Reference
4-AP Increased mRNA &
protein
shRNA knockout High firing rate from 4-AP remained high Anti-epileptic (Pozzi et al.
2013)
Kindling Increased mRNA &
protein






– – Anti-epileptic (Chmielewska
et al. 2020)
PTZ – Creloxp knockout More PTZ required to initiate seizure Pro-epileptic (M. Liu et al.
2012)
Kainate Increased mRNA – – – (Palm et al.
1998)
Kainate Increased mRNA – – – (Spencer et al.
2006)
Kainate Increased mRNA &
protein
– – – (Brennan et al.
2016)
Kainate Increased protein Decoy
oligonucleotides




Kainate Increased protein Viral knockdown Reduced & less severe seizures Pro-epileptic (Carminati et al.
2019)










Rescued hippocampal neurons Pro-neurodegeneration (Noh et al.
2012)
Ischemia Increased protein Pyrvinium pamoate Rescued neurons Pro-neurodegeneration (Kaneko et al.
2014)
Ischemia Increased protein – – – (Hwang et al.
2014)




Ischemia Increased protein Valproic acid Protected against oxygen-glucose depriva-
tion (OGD)-induced cell damage
Pro-neurodegeneration (Luo et al.
2020)
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Bcl2L13 to inhibit apoptosis and neuronal excitability and
increase latency period of epileptogenesis (Schouten et al.
2015; Brennan et al. 2016; Wang et al. 2016), while promot-
ing seizures through increased inflammation (X. Liu et al.
2019) in a REST-independent manner. In support of this, the
Baram group saw no overall effect on seizures, inflammation
or cell loss after rescuing post-seizure miR-124 downregula-
tion with a Sirt1 inhibitor EX-572 following kainate-induced
status epilepticus (Hall et al. 2017). Interestingly, REST and
Sirt1 are also implicated in the pathology of Huntington’s
disease, with increased expression of Sirt1 found in
Huntington’s disease-affected post-mortem brains (Baldo
et al. 2019). Huntington’s disease is associated with low levels
of the REST target BDNF (brain derived neurotrophic factor),
and restoration of BDNF can effectively reverse the
Huntington’s disease phenotype (Xie et al. 2010), suggesting
Sirt1 and REST may exacerbate the disease by downregula-
tion of BDNF.
The REST transporter protein PRICKLE/RILP may play a
role in nuclear-cytoplasmic localization and transport of
REST, and mutations in PRICKLE/RILP which disturb its
function lead to Progressive Myoclonus Epilepsy (Bassuk
et al. 2008; Shimojo 2006). PRICKLE/RILP is also a compo-
nent of the wnt signalling pathway which is well known to
regulate REST expression directly (Nishihara et al. 2003).
Wnt signalling pathway dysregulation is consistently ob-
served in epilepsy and associated with aberrant neurogenesis
and cell death (Hodges and Lugo 2018). Furthermore,
antagonising the wnt inhibitor Dickkopf-1 has been found to
reduce kainate- and ischemia-induced excitotoxicity, neuronal
death and hippocampal sclerosis (Busceti et al. 2007;
Cappuccio et al. 2005). Therefore it will be useful to investi-
gate whether the REST upregulation observed in
epileptogenesis is regulated by changes in the wnt pathway.
REST represses HCN1 channels, dopamine receptor type 2,
and choline acetyltransferase
Following SE, REST has been shown to repress certain genes
involved in neuronal excitation and inhibition, and under-
standing these effects may help to elucidate its overall role
in the epileptogenic process. For example, REST binds to
potassium/sodium hyperpolarization-activated cyclic
nucleotide-gated channel 1 (HCN1) channels (D.S. Johnson
et al. 2007). HCN1 channels contribute to control of excitabil-
ity in pyramidal cell dendrites in the hippocampus and ento-
rhinal cortex by attenuating excitatory input, and mice lacking
HCN1 channels are susceptible to epilepsy (Santoro et al.
2010). Kainate-induced SE in rats caused increased REST
protein and increased binding of REST to HCN1. Kainate
caused an increase in number of interictal bursts and cumula-
tive time spent in interictal activity, but this was prevented in
rats injected with REST decoy oligodeoxynucleotides at 1 or
2 days after kainate-induced SE, which blocked native REST
from binding and repressing HCN1. (McClelland et al. 2011).
This demonstrates a pro-convulsive role for REST in the
kainate model, through repression of the protective HCN1
channels.
REST may also play a pro-epileptic role through its repres-
sion of the dopamine receptor type 2 (DR2), with REST over-
expression causing reduced transcript expression of the recep-
tor (L. Lu et al. 2018), and increased DR2mRNA levels in the
striatum of REST conditional knockout mice (Yu et al. 2013).
Dopamine is understood to be involved in epileptogenesis,
with dopamine receptor types 1 and 2 having opposing roles.
Signalling through dopamine receptor type 1 (DR1) is pro-
epileptogenic while signalling through DR2 is anti-
epileptogenic (Bozzi and Borrelli 2013). DR2 knockout mice
have increased susceptibility to kainate and pilocarpine-
induced seizures and hippocampal cell death (Bozzi and
Borrelli 2002; Bozzi et al. 2000). Interestingly, DR2-like
binding sites were reduced in the caudate-putamen of
pilocarpine-treated rats (Yakushev et al. 2010), suggesting
DR2 downregulation could be a factor contributing to the
perpetuation of seizure in epileptogenesis. As REST levels
increase after seizure, this DR2 downregulation could be the
result of REST repression.
Another REST target gene of interest is choline acetyltrans-
ferase (Wood et al. 2003; Lönnerberg et al. 1996) which ca-
talyses the synthesis of acetylcholine. Cholinergic dysfunction
has been implicated in key mechanisms underlying temporal
lobe epilepsy, though the effects of ChAT depletion are un-
clear (Friedman et al. 2007). Overexpression of REST caused
repression of ChAT in cholinergic neurons (Lönnerberg et al.
1996), which could reflect an effect of the upregulated REST
levels seen in post-SE animal models. In support of this idea,
reduced ChAT activity after kainate injection was observed
within hours, and also 6 months later which correlated to
seizure severity (Baran et al. 2004; Guevara et al. 2002). If
REST represses ChAT after seizure this could contribute to
cholinergic dysfunction and epileptogenesis. More research
will help to elucidate this mechanism in vivo. In contrast to
the kainate model, no changes in ChAT activity were ob-
served after kindling (Walker et al. 1985).
The idea of a pro-epileptic role for REST in post-SE
models is supported by other groups. Carminati and col-
leagues developed a virally-delivered genetic switch for
inhibiting REST in hippocampal neurons in mice. Mice ex-
pressing the REST inhibitor showed less seizure activity in
response to kainate than control mice. Notably, REST inhibi-
tion also allowed the de-repression of a selection of REST
target genes including potassium channels (Hcn1, Hcn3,
Kcnc2, Kcnh1, Kcnip2, Kcnq1), synaptic genes (Gphn,
L1cam, Nrx1, Shank, Snap25, Syn 1, Syp and several Syt)
and genes involved in control of excitatory and inhibitory
currents (Gabra1, Gabrg2, Glra3, Sst, Gria2, Grin1, Grin2b)
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(Carminati et al. 2019). Similarly, in a PTZ seizure model,
threshold doses of PTZ that induced tonic-clonic seizures,
and median lethal doses, were higher in conditional REST
neuronal knockout mice than control mice. This demonstrates
that REST knockout mice are more resistant to PTZ-induced
seizures (M. Liu et al. 2012), suggesting REST incurs an
overall susceptibility to PTZ, similar to kainate.
Effects of REST after kindling
Kindling is a process of inducing an epileptic state in animal
models by applying short repeated sub-convulsive stimula-
tions, which can be either electrical or using chemoconvulsive
drugs. Over time this sensitises the brain to the stimulus and
creates a state of increasing excitability, beginning with brief
focal afterdischarges and culminating in full generalised sei-
zures (Sato et al. 1990). The electrical kindling animal model
of epilepsy was developed by Goddard (Goddard 1967). It
consists of repeated short, mild tetanic stimulations every 12
or 24 h for around 15 days inducing seizures of increasing
severity. In classic electrical kindling, seizures are short and
cell death and astrogliosis are not usually observed. Despite
the lack of noticeable neuronal loss or synaptic terminal de-
generation, aberrant sprouting of mossy fibers in the dentate
gyrus has been reported from electrical kindling (Sutula et al.
1988). Notably, ‘overkindling’ caused by very prolonged kin-
dling procedures can lead to the occurrence of spontaneous
seizures (Pinel and Rovner 1978), along with some cell death
and hippocampal sclerosis observed after 30 kindled seizures
(Cavazos and Sutula 1990). Different brain regions have been
electrically kindled, with the pyriform cortex and amygdala
requiring the least stimulations, and the hippocampus and
septal area requiring more stimulations to reach a kindled state
(Sato et al. 1990). NMDA receptor antagonists slowed elec-
trical kindling, suggesting their involvement in the process
(Cain et al. 1988). Kindling is proposed to be reflective of
epileptogenesis being driven in a controlled manner
(McIntyre et al. 2002), with early seizure observations in an-
imal models resembling complex partial seizures in the clinic,
and fully kindled animal’s behaviour resembling generalised
limbic seizures (Sato et al. 1990). Furthermore, specific sei-
zure types have been recreated through electrical kindling, and
antiepileptic drugs have been observed to give similar relief to
each seizure type in the kindled animal models as observed in
the clinic (Albright and Burnham 1980).
Chemical kindling is achieved with chemoconvulsive
drugs. In this review we will focus on PTZ as it is the most
commonly used drug in chemical kindling, and reflects the
model used in research on the role of REST in epilepsy.
PTZ kindling was first discovered by Mason and Cooper
(Mason and Cooper 1972) and was described as being similar
to the electrical kindling model proposed by Goddard
(Goddard 1967). In PTZ kindling, repeated subthreshold
doses of 20-50 mg/kg PTZ are injected into the peritoneum
(Yonekawa et al. 1980). PTZ quickly distributes through the
body and into the brain where it acts as an antagonist of
GABAA receptors, causing seizures of increasing severity
and duration. PTZ kindling protocols tend to be one injection
every 2 days for up to 43 days (Kanzler et al. 2018). PTZ
kindling models are often used for pharmaceutical screenings
but its mechanism of action is not well understood. Increased
number of NMDA receptors in rat hippocampus were ob-
served after PTZ kindling (Cremer et al. 2009), mirroring
what is seen in TLE patients, and suggesting PTZ-kindling-
induced epileptogenesis may be caused by increased sensitiv-
ity to glutamate (Brines et al. 1997). Mossy fibre sprouting is
observed in the CA3 region of the hippocampus but not in the
molecular layer of the dentate gyrus. Astrogliosis and oxida-
tive stress are observed, alongside blood brain barrier perme-
ability and upregulated BDNF (Uzüm et al. 2006; Zhu et al.
2015). Presence of neuronal death after PTZ kindling seems to
vary by study (Tian et al. 2009; Zhu et al. 2015), and altered
morphology of neurons has been described (Vasil'ev et al.
2013).
Both electrical and chemical kindling utilise the same prin-
ciple of repeated subthreshold stimulations causing neuronal
sensitisation to provoked seizure. One noteworthy difference
between the two is that chemoconvulsants diffuse throughout
the entire brain while electrical kindling begins in the region
of the brain the electrodes are implanted into. This allows
targeting of specific brain regions with electrical kindling,
making it highly appropriate for studies involving focal sei-
zures, whereas chemoconvulsant injection into the peritoneum
are most appropriate for generalised seizures. However, in the
affected brain regions the mechanisms appear similar in elec-
trical and chemical kindling. Neuronal death has been report-
ed in some PTZ kindling studies, and in a small percentage of
electrically kindled animals, with likelihood increasing the
longer the kindling procedure continues for (Zhu et al. 2015;
Cavazos and Sutula 1990). The potential for neuronal damage,
induction of status epilepticus and development of a state of
spontaneous seizures suggests that overkindling, from either
chemical or electrical stimulations, may share similarities in
mechanism and effects with the post-SE models (Pinel and
Rovner 1978).
REST downregulates BDNF and TrkB in epilepsy
Brain-Derived Neurotrophic Factor (BDNF) is an established
binding target of REST (Timmusk et al. 1999), and REST
represses BDNF following seizures in all types of animal
models examined. Inhibition of REST by decoy oligonucleo-
tides allowed rescue of BDNF expression (Soldati et al. 2011),
siRNA knockdown of REST caused a 60% increase in BDNF
mRNA (Conforti et al. 2013), and kainate induced BDNF
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mRNA and protein increase after 24 h in cre-loxp REST
knockout mice (Hu et al. 2011a, 2011b). A wealth of studies
have been done which show that mRNA of BDNF and its
receptor Tropomyosin receptor kinase B (TrkB) are upregulat-
ed in epilepsy models (Isackson et al. 1991; Nibuya et al. 1995;
Binder et al. 1999a; Dinocourt et al. 2006; Hu et al. 2011a,
2011b), and have strong pro-epileptic effects. Knocking down
or inhibiting BDNF and TrkB reduces seizures in vivo (Kokaia
et al. 1995; Binder et al. 1999b; Lähteinen et al. 2002; Kang
et al. 2015), while overexpression of BDNF produces mixed
results (Croll et al. 1999; Scharfman et al. 2002; Eftekhari et al.
2016). It is suspected that while BDNF is pro-convulsive, it can
lead to amore chronic dampening of excitation via activation of
neuropeptide Y, desensitisation of TrkB and alterations in chlo-
ride conductances, evidence of which is discussed in more de-
tail in the review of BDNF in epilepsy by Iugheti and col-
leagues (Iughetti et al. 2018).
Earlier this year the Szyndler group looked to investigate
the links between REST and BDNF in a model of rat kindling
with PTZ. The rats most resistant to kindling had significantly
more REST protein than rats less resistant to kindling, but
slightly less mRNA, which could have been due to an increase
in protein synthesis or a decrease in degradation. Increases in
BDNF were seen in kindling-resistant rats compared to the
rats in kindled groups combined. TrkB protein increased in
kindled rats but was not changed in kindling-resistant rats
(Chmielewska et al. 2020). Such observations are consistent
with the idea that increased REST repressed TrkB upregula-
tion and protected against epileptogenesis.
Phospholipase C gamma1 (PLCγ) has been implicated as
an important driver of epileptogenesis and is activated by the
BDNF TrkB pathway in pilocarpine and kindling mouse
models (He et al. 2010). Uncoupling of TrkB from PLCγ
following SE prevented temporal lobe epilepsy (Gu et al.
2015). TrkB may induce hyperexcitability by recruiting
PLCγ to help reduce expression of the K-Cl cotransporter
KCC2, resulting in a reduction of Cl− dependent hyperpolar-
izing postsynaptic current (Rivera et al. 2004). Interestingly,
KCC2 is directly regulated by REST in development, when it
is involved in the GABAergic switch from excitatory to in-
hibitory neurotransmission (Yeo et al. 2009), so its RE1 sites
might allow REST to contribute to its repression in adult
epileptogenesis. All the evidence suggests the TrkB increase
after seizure to be proconvulsant, and inhibition of TrkB ac-
tivity by REST repression of BDNF in the kindling model
reduces epilepogenesis.
REST may contribute to the antiepileptogenic effects
of the ketogenic diet
The ketogenic diet is a high fat, very low carbohydrate diet
which is used to control seizures in people with drug-resistant
epilepsy. Its mechanisms of action are not fully understood
but likely involve multiple pathways inducing antiseizure and
antiepileptogenic effects. Investigation of the role of glycoly-
sis in epilepsy has made use of 2-Deoxyglucose (2DG) to
inhibit glycolysis as a mimic for the ketogenic diet. In 2006
the Roopra group showed that 2DG application blocked
epileptogenesis in a rat electrical kindling model and
prevented post-seizure upregulation of BDNF and TrkB
mRNA, through enhanced repression by REST and the
REST co-repressor C-terminal-Binding Protein 1 (CtBP).
Glycolytic inhibition enhanced REST recruitment of the
NADH-sensitive CtBP. This interaction was disrupted by in-
creasing NADH levels as would occur during glycolysis, sug-
gesting glycolytic inhibition allows REST to bind CtBP more
strongly through a reduction of NADH and provide an en-
hanced level of gene repression (Garriga-Canut et al. 2006).
The requirement of REST for 2DG-mediated prevention of
electrical kindling was confirmed by the Xiong group, as
REST conditional knockout mice were resistant to the antiep-
ileptic effect of 2DG. However, the ketogenic diet blocked
electrical kindling in both control and REST knockout mice,
demonstrating that REST is not required for the antiepileptic
effects of the ketogenic diet (Hu et al. 2011a, 2011b). The
ketogenic diet has been shown to exert its antiepileptic effects
through a few different mechanisms (Boison 2017), but the
results mentioned here suggest REST repression of BDNF to
be a contributory factor.
Effects of REST in homeostasis after 4-AP
Homeostatic plasticity is a regulatory adjustment in the
strength of neuronal firing in response to sustained excitatory
changes, and can be in the form of intrinsic excitability or
synaptic scaling. Work by the Baldelli group has implicated
REST in both types of plasticity in response to heightened
excitation by the Kv1 voltage gated K+ channel blocker and
convulsant 4-aminopyridine (4-AP) (Pecoraro-Bisogni et al.
2018; Pozzi et al. 2013). RESTwas found to protect against 4-
AP-induced hyperexcitability through downregulation of
voltage-gated sodium channels. Cultured hippocampal neu-
rons were transfected with REST, which reduced 4-AP in-
duced neuronal excitability and sodium current density, as
well as downregulating expression of voltage-gated sodium
channels. Scrambled shRNA 4AP-treated neurons had a high
initial firing rate which then reduced by 48 h, but in REST
shRNA knockout neurons, 4-AP induced a high firing rate
which remained high, suggesting REST was necessary for
the reduction in network excitability (Pozzi et al. 2013). The
group also later showed that 4-AP induced prolonged hyper-
excitability and REST increase which decreased the size of the
synaptic vesicle pools. This groups work demonstrates how
synaptic scaling and intrinsic homeostatic plasticity are both
regulated by REST, to prevent hyperexcitability (Pecoraro-
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Bisogni et al. 2018). Similar to in the in vivo kindling models
of epileptogenesis, acute in vitro 4-AP seizure models increase
neuronal excitability without most of the excitotoxicity and
cell death observed in post-SE models. In accordance with
kindling models, 4-AP models portray REST as protective
against hyperexcitability.
Effects of REST after ischemia
Epilepsy can be acquired in response to a stroke, traumatic brain
injury, tumour or infection. Most strokes are ischemic, and
ischemic injury leads to excitotoxicity, inflammation, neuron
and astrocyte death, mitochondrian dysfunction and free radical
production (George and Steinberg 2015). Following ischemia,
microglia and astrocytes are activated which trigger an inflam-
matory response by upregulation of NF-kB (W. Liu et al.
2011). Hypoxia from hypoperfusion quickly causes brain dam-
age. Large infarctions are associated with recurrent post-stroke
seizures (Gupta et al. 1988). Around 14% of surviving ischemic
stroke patients develop seizures (Kotila and Waltimo 1992),
referred to as post-stroke epilepsy as the seizures are spontane-
ous and repetitive. The risk of post-stroke seizures is associated
with the severity of the stroke and resulting brain damage, dis-
ability after stroke and hippocampal involvement (Myint et al.
2006). Post-stroke epilepsy seems to be generated by hypoxia
and metabolic dysfunction, breakdown of the blood brain bar-
rier, glutamate excitotoxicity and the loss of neurovascular unit
integrity (Reddy et al. 2017). Animal ischemic stroke models
can be global or focal. Global cerebral ischemia is induced by 2
or 4 vessel occlusion. Focal cerebral ischemia is transient and is
usually induced by middle cerebral artery occlusion (MCAO).
Twelve months after MCAO in primates, there were fewer
neurons and more glia in the hippocampus than in control
groups, but the infarct was restricted to cortical regions
(Ouyang et al. 2020). In summary, the ischemic model induces
some similar physical pathologies as the post-SE models, fo-
cussing heavily on neuron death, excitotoxicity, inflammation
and infarction, whilst usually lacking the neuronal hyperexcit-
ability observed in the post SE and kindling models.
In ischemia models REST increases consistently exacer-
bate cellular damage and may drive epileptogenesis.
Following ischemic insult, REST increase was inhibited by
injection of the casein kinase 1 (CK1) activator pyrvinium
pamoate. CK1 phosphorylates REST, targeting it for
proteasomal degradation. As well as blocking REST increase,
CK1 activation also rescued neurons from cell death (Kaneko
et al. 2014). The same year, the group identified miR-132 as a
target of REST in ischemia. miR-132 is important for synaptic
plasticity and synaptogenesis. REST depletion inhibited
ischemia-induced repression of miR-132 by REST.
Moreover, overexpression of miR-132 in vivo by lentiviral
delivery conferred protection of neurons against ischemia-
induced cell death (Hwang et al. 2014). REST upregulation
after MCAO-induced ischemia-reperfusion was also associat-
ed with a decrease in HCN1. This was rescued by valproic
acid, which also protected neurons from damage caused by
oxygen-glucose deprivation and reoxygenation (Luo et al.
2020). Another mechanism REST uses to amplify neurode-
generation is through repression of the anti-excitatory AMPA
receptor subunit GluR2 (Huang et al. 1999). GluR2 has anti-
excitatory effects through restriction of Ca2+, and GluR2
knockdown in animal models is associated with enhanced
epileptogenesis by increasing the permeability of AMPA re-
ceptors to Ca2+ ions (Sanchez et al. 2001). REST mRNA and
protein increased after ischemia causing repression of GluR2
alongside Grin1 and other genes, while REST knockdown
prevented GluR2 repression and rescued neurons from
ischemia-induced death of hippocampal neurons in vivo
(Calderone et al. 2003; Noh et al. 2012). GluR2 is also re-
duced after SE (Grooms et al. 2000). After MCAO-induced
REST increase, REST siRNA knockdown caused consider-
able upregulations in GluR2 and Grin1, as well as BDNF.
REST knockdown also improved functional recovery, apo-
ptosis and infarct volume (Morris-Blanco et al. 2019). REST
repression of GluR2 and Grin1 after ischemic insult promotes
brain damage (Mehta et al. 2015). It is hypothesised that Ca2+
permeable AMPA receptors may cause excitotoxic cell death
to interneurons, which increases overall hyperexcitability by
reducing inhibitory GABA signalling (Rogawski and
Donevan 1999). In contrast, REST has also been shown to
repress expression of the MOR-1 (mu opioid receptor 1) with-
in inhibitory interneurons in the CA1 hippocampal region
following ischemic insult which may be neuroprotective.
Knocking down MOR-1 through antisense oligonucleotides
or the MOR-1 antagonist naloxone conferred protection of
pyramidal neurons to ischemia-induced cell death, potentially
by disinhibiting GABA release from inhibitory interneurons,
demonstrating MOR-1 to be pathological in this model
(Formisano et al. 2007). Despite REST’s protective potential
with MOR-1, research clearly indicates REST to drive neuron
death in ischemic models, through GluR2.
In addition to ischemia, REST’s involvement in cell death
occurring from other types of insult seems likely.
Methylmercury has been shown to cause neurotoxicity through
increased expression of REST and deacetylation of histone
protein H4 in SH-SY5Y cells, and in the mouse cerebellar
granule cell layer. The methylmercury-induced neurotoxicity
in SH-SY5Y cells was prevented by the HDAC inhibitor
trichostatin-A through prevention of H4 deacetylation (Guida
et al. 2016). REST has also been shown to increase after in-
flammation in vitro in dorsal root ganglia neurons, which re-
pressed expression of Kv7 channel subunits KCNQ2 and
KCNQ3, and reduced the Kv7 current. Kv7 channels are an-
ti-excitatory, producing a subthreshold potassium current
which stabilises the resting membrane potential, so their
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repression by REST would be expected to increase
excitability (Mucha et al. 2010). Mutations in the subunits
composing Kv7 channels are associated with the neonatal ep-
ilepsy Benign Familial Neonatal Convulsions, and the antiep-
ileptic drug Retigabine works by opening Kv7 channels. This
mechanism was characterised further for its role in chronic
pain (Rose et al. 2011; Zhang et al. 2019). Further research
will determine whether a parallel mechanism of increased
REST downregulating anti-excitatory Kv7 channels in the
CNS could drive epileptogenesis following ischemia or SE.
Why does REST show different function
in different models?
This review describes the research which has investigated the
function of the REST upregulation seen following a brain
insult which could provoke seizures. Table 1 shows the com-
monality of REST mRNA and protein increasing consistently
in all studies and models. REST regulates many different
genes which can individually contribute pro- or anti-
excitatory effects (see Fig. 1), and the balance between all of
these factors may determine whether or not an individual goes
on to develop epilepsy following an initial brain insult.
SE in animal models can be induced by an array of
chemoconvulsants including pilocarpine, picrotoxin,
bicuculline, kainate, or PTZ. Post-SE models have been de-
scribed as more accurate than kindling models in creating all
the features ofmesial temporal lobe epilepsy (TLE). The latent
period is particularly relevant for the process of
epileptogenesis, and the mossy fibre sprouting and hippocam-
pal sclerosis are common pathological hallmarks of TLE. SE
leads to an increase in mossy fiber sprouting, neuron death,
and increases in NMDA and AMPA receptor expression,
compared to kindled rats (Mathern et al. 1997). The presence
of any harmful secondary effects from kindling does seem to
depend upon the length of the kindling procedure. Classical
electrical kindling and most PTZ kindling procedures do not
induce spontaneous seizures or cause significant neuronal
damage, but more severe secondary effects are observed with
longer kindling protocols (Pinel and Rovner 1978). Kindling
is criticised as only being a partial model of epilepsy, recapit-
ulating hyperexcitability without neuronal damage, and is be-
ing used less commonly compared to post-SE models in re-
cent years. The main drawback of post-SE models is that the
degree of cell death and hippocampal sclerosis can be much
more pronounced than in epilepsy patients. The brain damage
in animal models occurs from the initial SE (Gorter et al.
2003). In contrast to pure epilepsy models, ischemia reliably
models the effects of stroke, though only 14% of ischemic
strokes lead to epilepsy (Kotila and Waltimo 1992).
In the kindling model REST is anti-excitatory, whereas in
models with an insult that induces cell death, REST seems to
augment the cell death and evoke seizures (See Table 1). This
difference may be facilitated by the level of REST increase
induced. In the PTZ kindling model, Chmielewska and col-
leagues reported REST protein to be around 650 pg/mg in
kindling-resistant rats compared to around 500 pg/mg in suc-
cessfully kindled rats and unkindled control rats
(Chmielewska et al. 2020). In contrast, kainate-induced SE
typically causes REST protein levels to increase 2–4 fold
within 48 h (McClelland et al. 2011; Carminati et al. 2019;
Brennan et al. 2016). Similarly, REST protein is consistently
seen to increase 2–3-fold in the CA1 hippocampal region and
the peri-infarct cortical tissue at 12–48 h after ischemic insult,
though no significant changes are observed in the CA3 region
or the dentate gyrus (Calderone et al. 2003; Kaneko et al.
2014; Hwang et al. 2014; Morris-Blanco et al. 2019).
Therefore, small increases in REST protein may allow a ho-
meostatic downregulation of excitability in response to in-
creased neuronal activity, but large increases in REST may
lead it to adopt a more pathological role. Interestingly, expo-
sure of hippocampal neurons to 4-AP in vitro for 96 h led to a
7-fold increase in REST, which was reported to be anti-
excitatory (Pozzi et al. 2013). This could be because the
in vitro single cell nature of the experimental design did not
have the necessary factors to allow REST to become pro-sei-
zure. For example, REST expression by glial cells may also be
necessary for its pro-seizure effects. This suggests the level of
REST protein is not the only factor determining the role of
REST in epilepsy.
Kindling seems to depend on the upregulation of BDNF
and TrkB, with deletion of BDNF and TrkB reducing or
abolishing kindling effects, respectively (Kokaia et al. 1995;
He et al. 2004). TrkB contributes to the development of kin-
dling, and its levels are increased in successfully kindled rats,
but not kindling-resistant rats (Binder et al. 1999a;
Chmielewska et al. 2020). Kindling-resistant mice also had
increased recruitment of CtBP by REST at the BDNF promot-
er (Potter et al. 2010). In normal physiological fluctuations in
excitability, REST likely acts as a brake by repressing BDNF
and TrkB, allowing excitability levels to return to normal.
Successful kindling provokes this homeostatic mechanism
but the modest REST increase involved is not great enough
to completely prevent an increase in BDNF and TrkB, so a
kindled state develops. There is other evidence of REST act-
ing in a neuroprotective manner in healthy brains. REST
levels rise in healthy brains during ageing, preventing oxida-
tive stress and repressing genes involved in the promotion of
Alzheimer’s disease (T. Lu et al. 2014). During ageing neuro-
nal excitation increases. REST represses genes involved in
excitation, with reduced excitation associated with increased
lifespan (Zullo et al. 2019). The combined evidence suggests
that in healthy brains, REST upregulation allows a protective
reduction in neuronal excitability, protection against oxidative
stress and increasing longevity.
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SE and ischemic insults appear to cause a larger increase in
REST than kindling, and this additional REST may cause it to
impact additional pathways. GluR2 protein is decreased by
around 40% in CA1 and CA3 pyramidal neurons 24 h after
kainate-induced SE, which is associated with neuronal death
(Grooms et al. 2000). Ischemic insult leads to a reduction in
GluR2 protein of over 40% in CA1 after 48 h (Calderone et al.
2003; Noh et al. 2012). In contrast, after kindling, no reduc-
tion of GluR2 protein is observed in the hippocampus at all,
though a 20–30% reduction is seen in the piriform cortex/
amygdala and limbic forebrain regions (Prince et al. 1995).
This may suggest a correlation between increasing insult se-
verity and level of hippocampal REST increase, and GluR2
downregulation in the hippocampus, with the piriform cortex/
amygdala and limbic forebrain being affected by GluR2-
mediated damage first. Following SE or ischemia, the large
REST increase causes HDAC-dependent repression of
GluR2, which leads to neuron death through Ca2+ permeable
AMPA receptor-mediated excitotoxicity. This mechanism ex-
plains why REST is pro-neurodegenerative in ischemia
models. In kainate models, kainate causes seizures by activat-
ing AMPA receptors. The AMPA receptors are deficient in
GluR2 due to REST downregulation of GluR2 and are more
permeable to Ca2+, so activation by kainate furthers the
AMPAR-mediated excitotoxicity, inducing seizures.
Kainate-induced AMPAR-mediated currents were increased
in receptors lacking GluR2 (Iihara et al. 2001). REST acts in
a pro-epileptogenic fashion in the kainate model because its
post-seizure increase causes the downregulation of GluR2,






















































Fig. 1 The differential contributions of REST in seizure and ischemia
models in pyramidal neurons. REST has either an overall protective
(blue) or pathological (red) contribution to the effects of kindling and 4-
AP seizure models (left), or status epilepticus seizure models and ische-
mia models (right), respectively. An excitatory stimulus within the ‘nor-
mal’ range for neurons, such as kindling in vivo, or 4-AP in vitro, causes
membrane depolarization and Ca2+ influx through NMDA receptors and
voltage gated Ca2+ channels. The Ca2+ increase enhances expression of
BDNF and increases activity of Sirt1. This leads to an increase in the
transcription factor C/EBP which enhances expression of REST. REST
represses expression of voltage gated Na2+ channels and BDNF. BDNF
protein is secreted outside of the cell, where it binds to TrkB receptors,
activating PLCγ. PLCγ recruitment by TrkB represses expression of
KCC2 transporters, leading the cell to a state of hypersensitivity of cells
to excitatory stimuli. This process is downregulated by REST-mediated
repression, as is the expression of voltage gated Na2+ channels which
contribute to action potential spiking. Therefore the actions of
upregulated REST in this system lead to an overall homeostatic reduction
of excitability towards normal levels. In contrast, status epilepticus or
administration of chemoconvulsants such as kainate cause a greater ex-
cessive influx of Ca2+ to the cell, leading to a larger increase in REST
levels. In addition to the downstream effects seen in normal levels of
excitation (left of diagram), REST here is also able to repress HCN1
and the AMPA receptor subunit GluR2. The repression of GluR2 leads
to an increase in AMPA receptors lacking the GluR2 subunit, which have
increased permeability to Ca2+. This allows an excessively large Ca2+
influx, which is also triggered by status epilepticus. The excitotoxic death
of nearby interneurons induced by Ca2+ influx leads to reduced
GABAergic signalling to the pyramidal neuron. In combination with
the excessive Ca2+ influx, this reduced inhibition is sufficient to trigger
neuron death in ischemia models, and additional epileptiform activity in
chemoconvulsant seizure models. Repression of HCN1 expression by
REST also contributes to the epileptiform activity and neuron death trig-
gered by kainate exposure
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mediated cell death is likely a significant driving factor behind
epileptogenesis. Glutamate-mediated excitotoxicity is the
main cause of hippocampal pyramidal cell death in epilepsy,
through necrosis, apoptosis, and autophagy. Excitotoxicity
causes hyperactivation of glutamate receptors leading to in-
creased calcium influx into the cell and the mitochondria,
causing metabolic dysfunction, free radical generation, inhibi-
tion of protein synthesis and activation of nitric oxide synthase
(NOS), proteases, phospholipases, endonucleases. Activation
of NOS causes damage to the neuronal membrane and this cell
damage leads to seizures (Lorigados Pedre et al. 2013). A
similar effect is seen in the PTZ seizure model through atten-
uation of inhibitory GABA signalling (M. Liu et al. 2012). If
higher levels of REST are required to induce GluR2 repres-
sion than BDNF repression, this would suggest REST may
bind BDNF more strongly than GluR2. REST is known to
bind the GluR2 promoter less strongly than then NaII promot-
er (Myers et al. 1998), but research is needed to compare
REST binding to GluR2 or BDNF. In addition to GluR2,
grin1 and chrnb2 are also repressed by REST following ische-
mia (Noh et al. 2012), and mutations in both of these are
associated with seizures (Phillips et al. 2001; Lemke et al.
2016), highlighting them as more potentially interesting ave-
nues of investigation in REST-mediated epileptogenesis.
The exacerbation of neurodegeneration by REST may be
an important driver of epileptogenesis in post-stroke epilepsy
and temporal lobe epilepsy with hippocampal sclerosis. It may
be beneficial to investigate the function of REST in models of
traumatic brain injury (TBI), as this does not appear to have
been looked at. TBI is more likely than ischemic injury to
result in epilepsy. Like ischemia and SE, TBI leads to
excitotoxicity and cell death, inflammation and blood brain
barrier dysfunction (Sande and West 2010). Therefore, like
in ischemia and SE models, it seems likely that REST would
be strongly upregulated following TBI, which could contrib-
ute to neuronal death and encourage seizure activity.
Conclusion
Epileptogenesis involves a selection of cellular and molecular
changes following an initial brain insult and a latent phase,
which make neurons more susceptible to hyperexcitability
and spontaneous seizures. However, we are far from under-
standing the mechanisms responsible and knowledge of such
mechanisms may help identify therapeutic strategies. In addi-
tion to larger structural changes such as the loss of inhibitory
interneurons and aberrant axonal sprouting, changes at the
mRNA and protein levels have also been explored to uncover
some molecular pathways involved in seizure progression.
The abundance of data implicating REST in the process of
epileptogenesis makes it a strong candidate as a master switch,
triggering a cascade of downstream events to modulate
excitability of each individual neuron. Sirt1 activity increases
after insult, likely by sensing an increased metabolic demand
in the cell, and this represses miR-124, which allows upregu-
lation of REST (Chen et al. 2013; Brennan et al. 2016). The
likely involvement of REST in the antiepileptic effects of the
ketogenic diet has been demonstrated as it is activated by the
glycolysis inhibitor 2DG and represses the pro-convulsant
BDNF (Garriga-Canut et al. 2006). BDNF and its receptor
TrkB are both upregulated in epilepsy and their repression
by REST seems to be an important regulatory switch to pro-
tect against epileptogenesis (Isackson et al. 1991; Nibuya et al.
1995; Binder et al. 1999a, 1999b; Dinocourt et al. 2006).
REST downregulates voltage-gated sodium channels and
sizes of synaptic vesicle pools, reducing intrinsic excitation
and synaptic scaling (Pozzi et al. 2013; Pecoraro-Bisogni
et al. 2018), while its downregulation of GluR2 and HCN1
increases excitation (McClelland et al. 2011; Grooms et al.
2000; Sanchez et al. 2001; Huang et al. 1999). It seems likely
that REST homeostatically protects healthy brains from in-
creases in excitability through downregulation of BDNF and
TrkB, but takes on a pathological role post-seizure in epileptic
brains by repressing GluR2, helping to drive epileptogenesis.
For epileptic patients, modulation of specific REST pathways
could provide relief from seizure-induced brain damage and
epileptogenesis. More defined studies should unravel specific
roles of REST in particular types of seizure in the clinic and
assess for the potential to use REST modulation as a therapy.
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